GGrantIndex
← Leaderboards

Diane R Gold

Harvard University (Medical School)

$19,628,221
Attributed
$21,867,091
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.5M · FY200517
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17

Funding mix

By agency

NIH$31,729,841 · 9

By mechanism

R01$18,000,083 · 4
P01$12,255,769 · 2
R21$988,480 · 2
R56$485,509 · 1

Top collaborators

Others in their field

Top investigators on “Asthma

Research focus

AsthmaExposure ToSourcePathway InteractionsUnited StatesImmuneWheezingInflammationInflammatorySymptomsLifePublic Health Medicine (Field)CytokinePollutionChildLungResponseHypersensitivityChildhoodAllergensAllergicBaseMorbidity - Disease RateCells

Grant awards (43)

The Fetal and Childhood Environment, Oxidative Balance, Inflammation and Asthma$796,483
R01 · FY2017 · AI · contact PI
The Fetal and Childhood Environment, Oxidative Balance, Inflammation and Asthma$791,822
R01 · FY2016 · AI · contact PI
Cardiovascular Response to CAP Microbial Components in Controlled Human Exposures$263,770
R21 · FY2016 · ES · contact PI
The Fetal and Childhood Environment, Oxidative Balance, Inflammation and Asthma$793,809
R01 · FY2015 · AI · contact PI
Cardiovascular Response to CAP Microbial Components in Controlled Human Exposures$262,188
R21 · FY2015 · ES · contact PI
The Fetal and Childhood Environment, Oxidative Balance, Inflammation and Asthma$808,147
R01 · FY2014 · AI · contact PI
Lung VITamin D and OmegA-3 TriaL (Lung VITAL)$187,264
R01 · FY2014 · HL · contact PI
The Fetal and Childhood Environment, Oxidative Balance, Inflammation and Asthma$824,957
R01 · FY2013 · AI · contact PI
Lung VITamin D and OmegA-3 TriaL (Lung VITAL)$707,661
R01 · FY2013 · HL · contact PI
VDAART FLORA ANCILLARY STUDY$400,713
R01 · FY2013 · HL · contact PI
Lung VITamin D and OmegA-3 TriaL (Lung VITAL)$756,486
R01 · FY2012 · HL · contact PI
VDAART FLORA ANCILLARY STUDY$420,484
R01 · FY2012 · HL · contact PI
Climate Change and Cardiac Vulnerability in Humans$251,610
R21 · FY2012 · ES
Lung VITamin D and OmegA-3 TriaL (Lung VITAL)$770,156
R01 · FY2011 · HL · contact PI
The Epidemiology of Home Allergens and Asthma$485,509
R56 · FY2011 · AI · contact PI
VDAART FLORA ANCILLARY STUDY$458,999
R01 · FY2011 · HL · contact PI
Climate Change and Cardiac Vulnerability in Humans$210,912
R21 · FY2011 · ES
The Epidemiology of Home Allergens and Asthma$852,814
R01 · FY2010 · AI · contact PI
Lung VITamin D and OmegA-3 TriaL (Lung VITAL)$822,525
R01 · FY2010 · HL · contact PI
AMBIENT PARTICLES AND CARDIAC VULNERABILITY IN HUMANS$1,911,171
P01 · FY2009 · ES · contact PI
The Epidemiology of Home Allergens and Asthma$895,189
R01 · FY2009 · AI · contact PI
Diabetes, Cardiac Disease, and Pollution Vulnerability$350,438
P01 · FY2009 · ES · contact PI
AMBIENT PARTICLES AND CARDIAC VULNERABILITY IN HUMANS$1,974,761
P01 · FY2008 · ES · contact PI
The Epidemiology of Home Allergens and Asthma$693,069
R01 · FY2008 · AI · contact PI
Diabetes, Cardiac Disease, and Pollution Vulnerability$359,119
P01 · FY2008 · ES · contact PI
AMBIENT PARTICLES AND CARDIAC VULNERABILITY IN HUMANS$1,974,699
P01 · FY2007 · ES · contact PI
The Epidemiology of Home Allergens and Asthma$1,102,884
R01 · FY2007 · AI · contact PI
Diabetes, Cardiac Disease, and Pollution Vulnerability$368,887
P01 · FY2007 · ES · contact PI
AMBIENT PARTICLES AND CARDIAC VULNERABILITY IN HUMANS$13,538
P01 · FY2007 · ES · contact PI
AMBIENT PARTICLES AND CARDIAC VULNERABILITY IN HUMANS$1,961,104
P01 · FY2006 · ES · contact PI
The Epidemiology of Home Allergens and Asthma$1,153,847
R01 · FY2006 · AI · contact PI
Diabetes, Cardiac Disease, and Pollution Vulnerability$338,812
P01 · FY2006 · ES · contact PI
AMBIENT PARTICLES AND CARDIAC VULNERABILITY IN HUMANS$2,027,477
P01 · FY2005 · ES
The Epidemiology of Home Allergens and Asthma$918,693
R01 · FY2005 · AI
Diabetes, Cardiac Disease, and Pollution Vulnerability$363,722
P01 · FY2005 · ES
The Epidemiology of Home Allergens and Asthma$684,239
R01 · FY2004 · AI
EPIDEMIOLOGY OF HOME ALLERGENS AND ASTHMA$734,897
R01 · FY2003 · AI
EPIDEMIOLOGY OF HOME ALLERGENS AND ASTHMA$813,115
R01 · FY2002 · AI
CARDIOVASCULAR VULNERABILITY TO PARTICULATE EXPOSURE$196,218
P01 · FY2002 · ES
EPIDEMIOLOGY OF HOME ALLERGENS AND ASTHMA$920,077
R01 · FY2001 · AI
CARDIOVASCULAR VULNERABILITY TO PARTICULATE EXPOSURE$196,218
P01 · FY2001 · ES
EPIDEMIOLOGY OF HOME ALLERGENS AND ASTHMA$691,753
R01 · FY2000 · AI
CARDIOVASCULAR VULNERABILITY TO PARTICULATE EXPOSURE$219,605
P01 · FY2000 · ES